Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
MMP9 4318 CAPTOPRIL CHEMBL1560 inhibitor DrugBank 18501888, 12381651, 19057128, 15993560
MMP9 4318 CGS-27023A CHEMBL514138 inhibitor GuideToPharmacologyInteractions
MMP9 4318 METHYLDOPA CHEMBL459 PharmGKB
MMP9 4318 ILOMASTAT CHEMBL19611 inhibitor GuideToPharmacologyInteractions
MMP9 4318 URIDINE DIPHOSPHATE GLUCOSE CHEMBL375951 inhibitor GuideToPharmacologyInteractions
MMP9 4318 INCYCLINIDE CHEMBL2104970 TdgClinicalTrial
MMP9 4318 PRINOMASTAT CHEMBL75094 vaccine TALC
MMP9 4318 NIFEDIPINE CHEMBL193 PharmGKB
MMP9 4318 BEVACIZUMAB CHEMBL1201583 CIViC 26921265
MMP9 4318 CELECOXIB CHEMBL118 PharmGKB
MMP9 4318 GLUCOSAMINE CHEMBL606759 antagonist DrugBank 16756968, 12801482, 12405690, 17498959, 16616490
MMP9 4318 ANDECALIXIMAB CHEMBL3833374 inhibitor, antibody GuideToPharmacologyInteractions, ChemblInteractions
MMP9 4318 MARIMASTAT CHEMBL279785 inhibitor TdgClinicalTrial, TEND, DrugBank 11752352, 17234180, 12763661

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
MMP9 rs3918242 T lithium efficacy no Allele T is not associated with response to lithium in people with Bipolar Disorder as compared to allele C. 21437990 981954279
MMP9 rs2236416 G bevacizumab efficacy no Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A. 28045923 1448995815
MMP9 rs17577 A bevacizumab efficacy no Listed as rs2274756 in paper. Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G. 28045923 1448995822
MMP9 rs2274755 T bevacizumab efficacy no Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G. 28045923 1448995807
MMP9 rs3918242 T ulinastatin efficacy yes Allele T is associated with increased response to ulinastatin in people with Pancreatitis as compared to allele C. 31192912 1451144600
MMP9 rs3918242 CT Antihypertensives efficacy yes Statistics given for likelihood of non-response. Genotype CT is associated with decreased response to Antihypertensives, hydralazine, Methyldopa or nifedipine in people with Gestational hypertension as compared to genotype CC. 21769110 827698925
MMP9 rs3918242 CT + TT Methyldopa efficacy yes Statistics given for likelihood of non-response. Genotypes CT + TT are associated with decreased response to Methyldopa in people with Gestational hypertension as compared to genotype CC. 21769110 827698919